JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 47 filers reported holding JANUX THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,592,000 | +8.5% | 1,150,000 | +27.8% | 0.03% | +13.0% |
| Q2 2023 | $10,683,000 | -1.9% | 900,000 | 0.0% | 0.02% | -4.2% |
| Q1 2023 | $10,890,000 | +17.9% | 900,000 | +28.4% | 0.02% | +9.1% |
| Q4 2022 | $9,233,039 | +70.5% | 701,066 | +75.3% | 0.02% | +69.2% |
| Q3 2022 | $5,416,000 | +10.9% | 400,000 | 0.0% | 0.01% | +18.2% |
| Q2 2022 | $4,884,000 | -14.9% | 400,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $5,736,000 | -27.3% | 400,000 | 0.0% | 0.01% | -21.4% |
| Q4 2021 | $7,892,000 | -8.8% | 400,000 | 0.0% | 0.01% | -17.6% |
| Q3 2021 | $8,652,000 | -22.9% | 400,000 | -11.1% | 0.02% | -22.7% |
| Q2 2021 | $11,228,000 | – | 450,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 9,165,652 | $92,389,772 | 1.82% |
| BVF INC/IL | 4,579,818 | $46,164,565 | 1.24% |
| Samsara BioCapital, LLC | 360,414 | $3,632,973 | 1.11% |
| Orbimed Advisors | 3,317,927 | $33,444,704 | 0.71% |
| Old Well Partners, LLC | 10,300 | $103,824 | 0.09% |
| Corton Capital Inc. | 11,061 | $111,495 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,150,000 | $11,592,000 | 0.03% |
| XTX Topco Ltd | 13,636 | $137,451 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,067,468 | $20,823,593 | 0.01% |
| Alyeska Investment Group, L.P. | 175,000 | $1,764,000 | 0.01% |